SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Merck Stops Blood Cancer Drug Trials After Risk Assessment

Merck has stopped trials of a blood cancer drug following a risk assessment.

MRK

Related stories